Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by Accountprinceon Nov 30, 2022 1:43pm
321 Views
Post# 35140393

Infomed Negotiations Ongoing?

Infomed Negotiations Ongoing?They have to complete this - per the last disclosure - by the end of today deadline.  So I guess that means by midnight tonight Swiss time which would be 6 pm North American time.  So we will (should) get disclosure after the close of trading today and no later than Monday morning before the commencement of trading.  Presumably it will be good news and Infomed will approve the plan for Dialco moving forward.  Speculation seems to say the plan will involve others taking the lead in getting DIMI over the finish line ("when not if" per management).

Dialco is a very material asset in Spectral with substantial investment over time that has grown exponentially in value.  Management and those in governance have a fiduciary responsibility to do everything possible to protect the asset and realize full value for Spectral and all its shareholders.  So the time for performance is now at hand.  Let's hope the result achieved is in line with or better than Dialco's inherent value.
<< Previous
Bullboard Posts
Next >>